Lnc-mg is a long non-coding RNA that promotes myogenesis

Area of Science:

• Molecular Biology
• Genetics
• Muscle Physiology

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in myogenesis and skeletal muscle regeneration.
• The specific functions of lncRNAs in adult skeletal muscle stem cell differentiation and myogenesis remain largely uncharacterized.

Purpose of the Study:

• To identify and characterize novel lncRNAs involved in skeletal muscle development.
• To elucidate the role of a specific lncRNA, lnc-mg, in myogenesis and skeletal muscle stem cell differentiation.

Main Methods:

• Identification of a skeletal muscle-enriched lncRNA (lnc-mg).
• Conditional knockout and overexpression studies in mice to assess muscle phenotypes.
• In vitro analysis of primary skeletal muscle cells to evaluate differentiation.
• Mechanistic studies involving competing endogenous RNA (ceRNA) interactions with microRNA-125b and insulin-like growth factor 2.

Main Results:

• Conditional knockout of lnc-mg in mice led to muscle atrophy and reduced exercise endurance.
• Skeletal muscle-specific overexpression of lnc-mg resulted in muscle hypertrophy.
• lnc-mg expression increased during myogenic differentiation in vitro, and its overexpression enhanced differentiation.
• lnc-mg acts as a ceRNA for microRNA-125b, regulating insulin-like growth factor 2 protein levels.

Conclusions:

• lnc-mg is a novel, noncoding regulator essential for skeletal muscle development and regeneration.
• lnc-mg plays a critical role in promoting myogenesis and myogenic differentiation.
• The lnc-mg/microRNA-125b/insulin-like growth factor 2 axis is a key pathway in muscle cell regulation.